FindTrial
Sign In

Effect of Benzydamine hydrochloride gargle on total quantity of propofol doses in patients undergoing ERCP- A clinical trial

Efficacy of Benzydamine hydrochloride on cumulative propofol consumption in patients undergoing endoscopic retrograde cholangiopancreatography – A randomized placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045354
Enrollment
200
Registered
2022-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere

Interventions

Intervention1: 0.15% Benzydamine hydrochloride mouthwash: 15 ml of 0.15% benzydamine hydrochloride mouthwash for a period of 20-30 seconds prior to start ERCP Control Intervention1: Normal saline: 15

Sponsors

Dr Bhanu Pratap Singh Gaur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting patients, American Society of Anesthesiologists (ASA) status I,II and III

Exclusion criteria

Exclusion criteria: History of allergy to the drugs, which will be used in the study, Patients who received analgesics or steroids 24 hours priorly, Patients with psychiatric disorders, Patients having severe hepatic, cardiac, or renal insufficiency, Patients who had throat wounds, Pregnant and lactating women, Procedure longer than 90 minutes

Design outcomes

Secondary

MeasureTime frame
Incidence of sore throat post sedationTimepoint: within 24 hours following procedure—

Primary

MeasureTime frame
cumulative propofol consumption in mg/kgTimepoint: 90 mins—

Countries

India

Contacts

Public ContactDr Bhanu Pratap Singh Gaur

Kalinga Institute of Medical Sciences

partha.mohapatra@kims.ac.in7205566361

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026